KMT5B and central nervous system cancer: Considering their significantly shorter overall survivals and the anti-tumoral effect of KMT5B, it could be suspected that this deletion–insertion in the C-terminal region may cause functional defect to KMT5B and de-repression of oncogenes in a subgroup of adult patients with pediatric-type glioma.